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Objective: To discuss the expression of mitogen-activated protein kinase 1 (MAPK1) in
the cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal
transition and invasion and metastasis.
Methods: Immunohistochemistry, western blot and RT-PCR method were employed to
detect the expression of MAPK1 protein and mRNA in cervical cancer tissue and adjacent
normal tissue. The constructed siRNA-MAPK1 was transferred into human cervical
cancer HeLa cells using Lipofectamine™2000. MTT method was used to detect the cell
vitality, transwell method to detect the cell invasion, and western blot to detect the
expression of matrix metalloproteinases (MMP)-2, MMP-9, tissue inhibitor of metal-
loproteinase (TIMP)-1, TIMP-2, zinc ﬁnger transcription factor (Snail), epithelial-
mesenchymal transition related protein (EMT) E-cadherin and vimentin in cells.
Results: The expression of MAPK1 protein and mRNA in the cervical cancer tissue was
signiﬁcantly higher than the one in the adjacent normal tissue (P < 0.01); after trans-
fecting the siRNA-MAPK1 into the human cervical cancer HeLa cells through liposome,
compared with the control group, its cell vitality was signiﬁcantly decreased (P < 0.01),
cell invasion was signiﬁcantly decreased (P < 0.01); expressed of MMP-2, MMP-9, Snail
and vimentin was signiﬁcantly decreased (P < 0.01), and expression of TIMP-1, TIMP-2
and E-cadherin was signiﬁcantly increased (P < 0.01).
Conclusions: Because of the high expression of MAPK1 in the cervical cancer tissue,
the interference in the expression of MAPK1 can signiﬁcantly inhibit the invasion and
metastasis of cervical cancer HeLa cells, which is related to the interference in the
expression of MMPs/TIMP and Snail-mediated generation of EMT.1. Introduction
The cervical cancer is the common gynecologic malignant
tumor and its morbidity ranks the second place and the mortality
the ﬁrst place among malignant tumors in women. Besides, with
the development of cytology screening technology, it's foundthat the onset of cervical cancer tended to be in young women,
with the gradually decreased incidence in the terminal stage, but
the signiﬁcantly increased incidence in the early stage [1,2].
Accordingly, based on the means of surgery, molecular
biological diagnosis and gene therapy, the possibility to cure
the cervical cancer has been greatly increased in the clinical
practice. However, the invasion and metastasis and local
recurrence of cervical cancer are still the major reasons for the
treatment failures of most patients. It is the difﬁculty that
should be settled urgently in the laboratory research, clinical
diagnosis and treatment. In consequence, to conﬁrm the
pathogenesis of cervical cancer and seek the new efﬁcient
markers of molecular biological diagnosis and gene therapy
for the cervical cancer, it will be capable to maximally inhibitaccess article under the CC BY-NC-ND
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the cervical cancer to the greatest extent.
The mitogen-activated protein kinase (MAPK) is the protein
kinase that consists of serine-threonine kinases. It is highly
conserved in the process of biological evolution. Without the
assistance of signal transduction system of second messenger, it
is capable to independently transducer the extracellular signals
into cells, in order to regulate the expression of related genes and
join in the physiological processes of mitosis, proliferation,
inﬂammation, invasion and metastasis of cells. According to
previous researches, many enzymes of MAPK pathway had the
abnormal expression in the female reproductive tract cancers,
breast cancer, ovarian cancer and cervical cancer [3,4]. Besides,
many chemotherapeutic drugs through such pathway have
been widely in the clinical practice. Most of scholars believed
that MAPK signaling pathway was the therapeutic target of
tumors. Researches mainly focused on the proliferation and
apoptosis of tumor cells [5], but there were limited researches
on the invasion and metastasis of tumor cells. MAPK1 is the
subfamily of MAPK pathway, which has the overexpression in
the follicular lymphoma [6]. It has also been proved that the
interference in the expression of MAPK1 in HeLa cells can
signiﬁcantly inhibit the proliferation of cancer cells and induce
the cell apoptosis [7,8]. Some research also found that the
activation of MAPK1 signaling pathway could signiﬁcantly
promote the generation of epithelial-mesenchymal transition
(EMT) in cervical cancer cells [9]. It indicated that MAPK1 had
the abnormal expression in the cervical cancer and it's closely
related to the development of cervical cancer, but its speciﬁc
mechanism of action has been unknown. Accordingly, in this
study, the immunohistochemistry, western blot and RT-PCR
method were employed to detect the expression of MAPK1
protein and mRNA in the cervical cancer tissue and adjacent
normal tissue. Besides, according to the interference in the
expression of MAPK1 in HeLa cells of cervical cancer, it is to
discuss the effect and speciﬁc effect of MAPK1 gene silencing
on the invasion and metastasis of HeLa cells and EMT in vitro.
2. Materials and methods
2.1. Samples
A total of 20 samples of cervical cancer tissue and 20 sam-
ples of adjacent normal tissue that were surgically removed by
surgical excision in this hospital from June 2014 to June 2015
were collected. All patients had not received the chemotherapy
before the operation, but they were diagnosed by the patholog-
ical and imaging examination.
2.2. Reagents and instruments
The human cervical cancer HeLa cells was purchased from
Cell Bank of Type Culture Collection of Chinese Academy of
Sciences (Registered No.: TCHu187); siRNA Tim-3 and control
were synthesized by Shanghai GenePharma Co, Ltd.; the rabbit
anti metalloproteinases (MMP)-2, MMP-9, tissue inhibitor of
metalloproteinase (TIMP)-1, TIMP-2, Snail, E-cadherin,
vimentin monoclonal antibody were purchased from Epitmics;
methyl thiazolyl tetrazolium from Gibco; fetal bovine serum,
DMEM culture medium from Hyclone; transwell chamber from
Corning, mini vertical electrophoresis tanks and mini Trans-blotelectrophoresis tank from Beijing Liuyi Instrument Factory; and
ChemiDoc™ XRS gel imaging system from Bio-Rad.
2.3. Detection of expression of MAPK1 in cervical
cancer tissue by RT-PCR
The total RNA was extracted by referring to the instruction
manual of trizol kit (Invitrogen) and the extraction was performed
in the condition without RNAase. Primers were as follows:
MAPK1 upstream primer: TGGATTCCCTGGTTCTCTC-
TAAAG, downstream primer: GGGTCTGTTTTCCGAG-
GATGA; reference GADPH upstream primer: AAAAACC-
TGCCAAATATGATGACA, downstream primer: AGCTTGA-
CAAAGTGGTCGTTGA. RNA was reversely transcripted into
cDNA through one-stop RT-PCR kit and then PCR ampliﬁcation
was performed. A total of 5 mL ampliﬁcation product was used for
the further detection using 2% agarose gel. Primers were added
into 25 mL PCR reaction system respectively, with the reaction
conditions of degeneration at 94 C for 45 s, renaturation at 59 C
for 45 s and extension at 72 C for 60 s, with 35 cycles. The UV
spectrophotometer was used to detect the electrophoretic bands
and take the photos.
2.4. Detection of expression of MAPK1 protein in
cervical cancer tissue by immunohistochemical assay
Samples were deparafﬁnized with dimethylbenzene, dehy-
drated with anhydrous, 95% and 80% ethanol, washed with the
running water, repaired with the antigen retrieval, closed with
the horse serum, closed with primary antibody, closed with
secondary antibody, immersed in the hematoxylin, immersed in
the hydrochloric acid alcohol, washed with the running water
until it appeared to be antiblue, dehydrated with the gradient
ethanol, transparented with dimethylbenzene, dried and then
mounted with the neutral resin, and the microscopic examina-
tion. The positive staining of MAPK1 appeared to be light
yellow and brown yellow, which was located in the cytoplasm.
2.5. Detection of vitality of cervical cancer HeLa cells
by MTT
The human cervical cancer HeLa cells were seeded onto 96-
well plate. When the conﬂuency of cells reached to 70%, it was
transfected with siRNA-MAPK1 (synthesized by Ambion) and
NC using Lipofectamine™2000 respectively. 48 h after the
transfection, 20 mL 5 mg/mL MTT was added for the continuous
culture of 4 h and then the culture medium was sucked out. Af-
terwards, 150 mL DMSO was added in each well and then it was
shaken to fully dissolve the crystals. CD value was measured at
560 nm of analyzer of enzyme-linked immunosorbent assay.
2.6. Cell invasion assay
Matrigel basement membrane was evenly paved on the
micromembrane (5 mm) of Transwell chamber to be prepared as
the gel for further use. The human cervical cancer HeLa cells were
seeded onto 6-well plate. When the conﬂuency of cells reached to
70%, it was to transfect siRNA-MAPK1 and NC using Lip-
ofectamine™2000 respectively. Afterwards, cells were digested
and added in the upper chamber of Transwell, while the lower
chamber contained DEME medium with 5% fetal bovine serum
Figure 2. Expression of MAPK1 in cervical cancer tissue and adjacent
normal tissue detected by Western blot assay.
Figure 3. Expression of MAPK1 in cervical cancer tissue and adjacent
normal tissue detected by RT-PCR.
Figure 4. Effect of MAPK1 on vitality of human cervical cancer HeLa
cells detected by MTT. Compared with the control group, **P < 0.01.
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taken out and washed, using the paraformaldehyde for the ﬁxa-
tion. It was then stained with the crystal violet. The number of
membrane-penetrating cells in ﬁve ﬁelds was counted under the
inverted optical microscope and themean number of cells for each
ﬁeld was calculated to represent the invasion ability of cells.
2.7. Western blot assay
RIPA lysis buffer was added in the collected cells. It was put in
Vortex instrument for 30 s of shaking every 10 min. After 40 min,
it was centrifuged at 4 C and 10000 rpm for 10 min. The su-
pernatant was sucked carefully to obtain the total protein. The
protein concentration was measured with BCA kit. The protein
loading buffer was treated with SDS gel electrophoresis and then
it was transferred with the wet method. Then the ﬁlm was
immersed into the primary antibody solution for the incubation at
4 C over night. After being washed, it was immersed into the
secondary antibody solution for the incubation at the room tem-
perature for 1–2 h. Afterwards, the ﬁlmwas taken out andwashed,
while ECL reagent was added on the ﬁlm for the exposure in the
gel imaging system. Statistics was performed on the gray value of
each antibody band using ‘Quantity one’ software.
2.8. Statistical analysis
The results were expressed as mean ± SD, with three repeats
for each set of data at least. The t test was employed and
P < 0.05 was meant to be signiﬁcant difference. All data were
treated using SPSS 17.0.
3. Results
3.1. Expression of MAPK1 in cervical cancer tissue and
adjacent normal tissue detected by
immunohistochemical assay
As shown in Figure 1, compared with the adjacent normal
tissue, the positive expression of MAPK1 in the cervical cancer
tissue was signiﬁcantly higher [(0.29 ± 0.00) vs. (10.21 ± 1.38)]
(P < 0.01).
3.2. Expression of MAPK1 in cervical cancer tissue and
adjacent normal tissue detected by Western blot assay
As shown in Figure 2, similar with the result of immuno-
histochemistry, compared with the adjacent normal tissue, theFigure 1. Expression of MAPK1 in cervical cancer tissue and adjacent norma
A: adjacent normal tissue; B: cervical cancer tissue.expression of MAPK1 protein in the cervical cancer tissue was
signiﬁcantly higher [(0.38 ± 0.05) vs. (4.86 ± 0.35)] (P < 0.01).
3.3. Expression of MAPK1 in cervical cancer tissue and
adjacent normal tissue detected by RT-PCR
As shown in Figure 3, in line with the trend of protein
expression, compared with the adjacent normal tissue, the
expression of MAPK1 mRNA was signiﬁcantly higher in thel tissue detected by immunohistochemical assay.
Figure 5. Effect of MAPK1 on the invasion of human cervical cancer HeLa cells detected by Transwell method.
Compared with the control group, **P < 0.01.
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(P < 0.01).
3.4. Effect of MAPK1 on vitality of human cervical
cancer HeLa cells by detected MTT
As shown in Figure 4, after transfecting siRNA-MAPK1 in
HeLa cells, the results of MTT assay showed that, compared
with the control group, the cell vitality in the transfection group
was signiﬁcantly decreased (P < 0.01).
3.5. Effect of MAPK1 on invasion of human cervical
cancer HeLa cells detected by Transwell method
As shown in Figure 5, after transfecting siRNA-MAPK1 in
HeLa cells, the results of transwell invasion assay showed that,
compared with the control group, the number of cell invasion in
the transfection group was signiﬁcantly decreased
[(217.34 ± 19.35) vs. (93.94 ± 9.97) (P < 0.01).Figure 6. Effect of MAPK1 on expression of MMP-2 and TIMP-2 in
human cervical cancer HeLa cells.
Compared with the control group, **P < 0.01.3.6. Effect of MAPK1 on expression of MMP-2 and
TIMP-2 in human cervical cancer HeLa cells
As shown in Figure 6, after transfecting siRNA-MAPK1 in
HeLa cells, the results of western blot assay showed that,
compared with the control group, the expression of MMP-2 was
decreased and the expression of TIMP-2 was signiﬁcantly
increased in the transfection group (P < 0.01).
3.7. Effect of MAPK1 on expression of MMP-9 and
TIMP-1 in human cervical cancer HeLa cells
As shown in Figure 7, after transfecting siRNA-MAPK1 in
HeLa cells, the results of western blot assay showed that,
compared with the control group, the expression of MMP-9 was
decreased and the expression of TIMP-1 was signiﬁcantly
increased in the transfection group (P < 0.01).Figure 7. Effect of MAPK1 on expression of MMP-9 and TIMP-1 in
human cervical cancer HeLa cells.
Compared with the control group, **P < 0.01.
Figure 8. Effect of MAPK1 on expression of Snail, E-cadherin and
vimentin in human cervical cancer HeLa cells.
Compared with the control group, **P < 0.01.
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and vimentin in human cervical cancer HeLa cells
As shown in Figure 8, after transfecting siRNA-MAPK1 in
HeLa cells, the results of western blot assay showed that,
compared with the control group, the expression of Snail and
vimentin was decreased and the expression of E-cadherin was
increased in cells, with the statistically signiﬁcant difference
(P < 0.01).
4. Discussion
The cervical cancer is the common gynecologic malignant
tumor and its morbidity ranks the second place that is second
only to the breast cancer and the mortality the ﬁrst place among
malignant tumors in women. The invasion and metastasis are
still the major reasons for the treatment failures and death of
most patients. Therefore, it is of critical importance to discuss
the malignant biological behavior of cervical cancer cells and the
speciﬁc molecular biological mechanism of occurrence and
development.
The invasion and metastasis of tumor is the biological pro-
cess that involves multiple steps and factors and the complicated
process with the interaction between the tumor cells, host cells
and extracellular matrix. In such process, the proliferation of
tumor cells is increased, the adhesion decreased and components
of extracellular matrix degraded. Accordingly, the tumor cells
are migrated and its invasion is enhanced to induce the tumor for
the motion along the distant and deep direction. MMPs is themost important set of proteases to degrade the extracellular
matrix, which play a key role in the invasion and metastasis of
tumor cells and the key enzyme to be involved in these pro-
cesses. MMP-2 and MMP-9 are two MMPs that have been
studied thoroughly. MMP-2 can not only degrade the gelatin IV
collagen in the extracellular matrix and promote the inﬁltration
of tumor cells around along the injured basement membrane, but
also promote the invasion and metastasis of tumor through the
new capillaries, as the indicator for the inﬁltration and invasion
of malignant tumor. MMP-9 is some kind of proteolytic enzyme
that is secreted by many cells. It is the enzyme with the largest
molecular weight among MMPs, which can degrade the extra-
cellular matrix and basement membrane and thus enhance the
ability of cell motion and promote the spread and metastasis of
tumor. TIMP is the speciﬁc inhibitor of MMP, which can
maintain the normal physiological functions of extracellular
matrix and has the abnormal expression in the tumor tissue [10].
The expression of MMP-2 and MMP-9 was extremely high in
the samples of cervical cancer, which was closely related to the
prognosis of patients [11]. MMP-2 had the high expression, but
TIMP-2 the low expression. Besides, TIMP-2 was the inde-
pendent predicator of univariate survival [10]. The high
expression of TIMP-1 in HeLa cells could inhibit the invasion
[12]. By up-regulating the expression of TIMP-1 and down-
regulating the expression of MMP-9, it could signiﬁcantly
inhibit the migration of Hela cells [13], which indicated that the
down-regulated expression of MMPs and the up-regulated
expression of TIMP could signiﬁcantly inhibit the invasion
and metastasis of cervical cancer cells.
EMT was ﬁrstly proved in the process of embryonic devel-
opment. More and more evidences have shown that EMT plays a
critical role in the tumorigenesis, including the local inﬁltration
and the metastasis and spread through the circulatory system, as
the characteristics of tumor cells with the strongest ability of in-
vasion. Besides, when the malignant tumor cells had EMT, it
could be regarded as the beginning of inﬁltration and metastasis
[14,15]. The characteristics of molecular marker for EMT is the
down-regulated expression of intercellular adhesion molecule
E-cadherin, and the up-regulated expression of a series of
mesenchymal markers, including N-cadherin, vimentin and
ﬁbronectin. The loss of E-cadherin contributes to the falling of
tumor cells from the primary site. Meanwhile, with the increased
degree of malignancy of tumors, the invasion is increased and the
recovery of E-cadherin function can reduce the invasion ability of
many kinds of tumor cells [16]. The vimentin is a protein of
intermediate ﬁlaments, which is mainly expressed in the stromal
tumors. The increased expression of vimentin contributes to the
invasion and metastasis of tumors and can also reduce the E-
cadherin-mediated intercellular adhesion, which can thus
promote the inﬁltration and metastasis of cells [17]. In the
cervical squamous cell carcinoma, the low expression of E-
cadherin and high expression of vimentin are all closely related
to the metastasis of tumor cells [18]. Therefore, the reversed
expression of EMT-related protein can inhibit the invasion and
metastasis of cancer cells. The zinc ﬁnger transcription factor
Snail was found in the fruit ﬂy, as the member of transcription
repressor Snail superfamily. The human Snail gene is located in
20th chromosome. Snail can be integrated with E-box sequence in
the promoter region of E-cadherin to inhibit the expression of E-
cadherin. The interference of RNA in the expression of Snail
could signiﬁcantly inhibit the generation of human lens epithelial
cells EMT that was induced by the transforming growth factor
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transfected with siRNA-Snail, the expression of E-cadherin was
increased and the ability of cell metastasis was decreased [20]. In
the hepatocellular carcinoma, Snail could up-regulate the
expression of MMP-2 and down-regulate the expression of E-
cadherin [21], which indicated that the down-regulated expression
of Snail in the cervical cancer cells could signiﬁcantly inhibit the
generation of EMT-related proteins and decrease the metastasis
ability of tumor cells.
MAPK family includes eight subfamilies of p38MAPK,
extracellular signal-regulated kinase (ERK), c-jun N-terminal
kinase (JNK), ERK3, big mitogen-activated protein kinase-1
(ERK5/BMK1), ERK-7, NLK and ERK8. The signal is trans-
mitted through MAPK pathway to activate the downstream
substrate ﬁnally and then start the expression of related genes,
which will cause the activation or transformation of biological
behaviors such as the cell proliferation, invasion and metastasis.
With the in-depth researches on the subfamilies of MAPK,
Huang et al. [7] adopted siRNA to interfere the expression of
MAPK1 and found that it could signiﬁcantly regulate the
growth, apoptosis and cytoskeleton of HeLa cells. Lwin et al.
[8] also proved that after the interference of siRNA in
MAPK1, it could signiﬁcantly inhibit the proliferation of
HeLa cells, which indicated that the expression of MAPK1
was closely related to the proliferation of cervical cancer cells.
However, there are limited researches on the relationship
between the invasion and metastasis of cervical cancer cells.
In consequence, on such basis, this study would discuss the
expression of MAPK1 in the cervical cancer tissue and
adjacent normal tissue and the effect of MAPK1 gene
silencing on the epithelial-mesenchymal invasion and metas-
tasis of cervical cancer cells.
In this study, the immunohistochemistry, western blot and
RT-PCR method were employed to detect the expression of
MAPK1 in the cervical cancer tissue and adjacent normal tissue.
Results showed that the expression of MAPK1 in the cervical
cancer tissue was higher than the one in the adjacent normal
tissue, which was in accordance with the ﬁndings of Wang et al.
[6] who found the overexpression of MAPK1 in the follicular
lymphoma through the gene analysis. Erkutlu et al. [22] proved
the low expression of MAPK1 in the glioblastoma multiforme.
It indicates that MAPK1 has the different functions in the
different tumor tissues, which can promote and also inhibit the
cancer gene, just playing the role of promotion in the cervical
cancer. The further interference of RNA in the expression of
MAPK1, the results of MTT assay showed that the expression
of MAPK1 was down-regulated and it signiﬁcantly reduced
the cell vitality, which was similar with the ﬁndings of Huang
and Lwin. Afterwards, the transwell assay was employed to
detect the MAPK1-siRNA transfected HeLa cells. Results
showed that the invasion ability was signiﬁcantly reduced.
Referring to the previous research, the protein tyrosine phos-
phatase receptor R activated MAPK signaling pathway to inhibit
the metastasis of cervical cancer [23]. The prion protein PrPc
could promote the generation of EMT in cervical cancer cells
through MAPK1 signaling pathway [9], which indicated that
the expression of MAPK1 was closely related to the invasion
and metastasis of cervical cancer cells and also related to the
generation of EMT. Accordingly, the western blot assay was
employed to further detect the expression of proteins related to
the invasion and metastasis of tumors. Results showed that the
decreased expression of MAPK could inhibit the expression ofMMP-2, MMP-9 and vimentin in HeLa cells and increase the
expression of TIMP-1, TIMP-9 and E-cadherin. It means that the
down-regulated expression of MAPK1 could interfere the
expression of MMPs/TIMP, interfere the generation of EMT and
inhibit the invasion and metastasis of HeLa cells. According to
previous researches, it targeted at the MAPK/Snail signaling
pathway to inhibit the metastasis of salivary adenoid cystic
carcinoma cells and siRNA-MAPK1 could signiﬁcantly inhibit
the activity and transcription expression of Snail2 gene promoter
[24]. MAPK1/2/ERK1/2 inhibitor PD98059 could signiﬁcantly
down-regulate the expression of Snail in the PDGF-BB-
induced mesenchymal stem cells and thus inhibit the cell inva-
sion [25], which indicated that siRNA-MAPK1 could also down-
regulate the expression of Snail to inhibit the invasion and
metastasis of tumor cells. Therefore, the results of in-depth study
in this experiment also proved that the down-regulated expres-
sion of MAPK1 could signiﬁcantly reduce the expression of
Snail. It indicates that the MAPK1 gene silencing can regulate
the expression of MMPs/TIMP and inhibit the Snail-mediated
EMT generation and expression of related proteins, in order to
inhibit the invasion and metastasis of tumor cells.
In conclusion, MAPK1 has the overexpression in the cervical
cancer tissue. The interference in the expression of MAPK1 can
signiﬁcantly inhibit the invasion and metastasis of cervical
cancer HeLa cells, which is related to the regulation on the
expression of MMPs/TIMP and the inhibition against the
expression of Snail-mediated EMT-related proteins.
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